These days, your reality is customizable.
Come what may, you can choose to live in a world where “the jab” will kill you and drinking human pee ensures good health and the president is not the president. And a whole world will be there to back you up.
Which is why, we’re choosing to believe this published study that says cannabinoids, the active ingredients in cannabis, block COVID-19 as well as its ensuing mutations from entering our cells. The news was brought to our attention on the Twitter of reporter Cerise Castle, pairing perfectly with our increased intake of edibles and bong hits to get us through an enduring pandemic.
What’s the science behind this claim, exactly? We were afraid you’d ask that. It’s complicated for someone like say, a writer who got a D- in both semesters in chemistry. But essentially, the report says this:
As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection-mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid acids from hemp (Cannabis sativa) were found to be allosteric as well as orthosteric ligands with micromolar affinity for the spike protein. In follow-up virus neutralization assays, cannabigerolic acid and cannabidiolic acid prevented infection of human epithelial cells by a pseudovirus expressing the SARS-CoV-2 spike protein and prevented entry of live SARS-CoV-2 into cells. Importantly, cannabigerolic acid and cannabidiolic acid were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2.